Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SHS CL A
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
527,620
-
Shares change
-
+527,620
-
Total reported value, excl. options
-
$311,428
-
Value change
-
+$311,428
-
Number of buys
-
5
-
Price
-
$0.5919
Significant Holders of PROKIDNEY CORP. - SHS CL A (PROK) as of Q2 2025
5 filings reported holding PROK - PROKIDNEY CORP. - SHS CL A as of Q2 2025.
PROKIDNEY CORP. - SHS CL A (PROK) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 527,620 shares
.
Largest 5 shareholders include MARSHALL WACE, LLP (464,812 shares), Catalyst Funds Management Pty Ltd (61,100 shares), EverSource Wealth Advisors, LLC (1,017 shares), Fortitude Family Office, LLC (490 shares), and SBI Securities Co., Ltd. (201 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.